Literature DB >> 10583598

Up-modulation of interferon-gamma mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells.

L Matera1, M Contarini, G Bellone, B Forno, A Biglino.   

Abstract

Prolactin (PRL) has been shown to participate in lymphocyte activation. In particular, the constitutive natural killer (NK) and the lymphokine-activated killer (LAK) cytotoxicity of CD56+ CD16+ cells is increased by its physiological to supraphysiological concentrations. As PRL has been shown to up-regulate the production of interferon-gamma (IFN-gamma) by peripheral blood mononuclear cells, we studied its effect on IFN-gamma production by NK cells as a possible mechanism of autocrine activation of cytotoxicity. Released and intracellular IFN-gamma, as well as IFN-gamma mRNA expression, were increased by pituitary and recombinant human PRL, which stimulated optimal NK and LAK cytotoxicity. Treatment with blocking anti-IFN-gamma monoclonal antibody (mAb) selectively affected PRL-increased killing of K562 targets, demonstrating that PRL-mediated enhancement of spontaneous cytotoxicity depends, at least in part, on up-regulation of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583598      PMCID: PMC2326946          DOI: 10.1046/j.1365-2567.1999.00893.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  39 in total

Review 1.  Structure and function of human growth hormone: implications for the hematopoietins.

Authors:  J A Wells; A M de Vos
Journal:  Annu Rev Biophys Biomol Struct       Date:  1993

Review 2.  Prolactin receptor signal transduction in cells of the immune system.

Authors:  C V Clevenger; D O Freier; J B Kline
Journal:  J Endocrinol       Date:  1998-05       Impact factor: 4.286

3.  Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells.

Authors:  L Matera; G Bellone; J J Lebren; P A Kelly; E L Hooghe Peters; P F Di Celle; R Foa; M Contarini; G Avanzi; V Asnaghi
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

4.  Regulation of prolactin secretion in the human B-lymphoblastoid cell line IM-9-P3 by dexamethasone but not other regulators of pituitary prolactin secretion.

Authors:  B Gellersen; G E DiMattia; H G Friesen; H G Bohnet
Journal:  Endocrinology       Date:  1989-12       Impact factor: 4.736

5.  Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine.

Authors:  D H Russell; R Kibler; L Matrisian; D F Larson; B Poulos; B E Magun
Journal:  J Immunol       Date:  1985-05       Impact factor: 5.422

6.  Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors.

Authors:  A Cesano; E Oberholtzer; M Contarini; M Geuna; G Bellone; L Matera
Journal:  Immunopharmacology       Date:  1994 Jul-Aug

7.  The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine.

Authors:  P N Riskind; L Massacesi; T H Doolittle; S L Hauser
Journal:  Ann Neurol       Date:  1991-05       Impact factor: 10.422

Review 8.  Prolactin and growth hormone in the regulation of the immune system.

Authors:  R R Gala
Journal:  Proc Soc Exp Biol Med       Date:  1991-10

9.  The proline-rich motif (PRM): a novel feature of the cytokine/hematopoietin receptor superfamily.

Authors:  K D O'Neal; L Y Yu-Lee
Journal:  Lymphokine Cytokine Res       Date:  1993-10

10.  Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications.

Authors:  I C Chikanza; P Petrou; G Chrousos; G Kingsley; G S Panayi
Journal:  Br J Rheumatol       Date:  1993-06
View more
  7 in total

Review 1.  Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.

Authors:  Elizabeth Ann L Enninga; Shernan G Holtan; Douglas J Creedon; Roxana S Dronca; Wendy K Nevala; Simona Ognjanovic; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2014-04       Impact factor: 7.616

Review 2.  Prolactin and autoimmunity.

Authors:  Annamaria De Bellis; Antonio Bizzarro; Rosario Pivonello; Gaetano Lombardi; Antonio Bellastella
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions.

Authors:  L Matera; A Galetto; M Geuna; K Vekemans; E Ricotti; M Contarini; F Moro; G Basso
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

4.  Prolactin has a pathogenic role in systemic lupus erythematosus.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Honorio Torres-Aguilar; Carmen Navarro; Monica Vazquez Del Mercado; Luis R Espinoza
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 5.  Exploring immunomodulation by endocrine changes in Lady Windermere syndrome.

Authors:  M R Holt; J J Miles; W J Inder; R M Thomson
Journal:  Clin Exp Immunol       Date:  2019-02-27       Impact factor: 4.330

6.  Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells.

Authors:  S Gerlo; P Verdood; E L Hooghe-Peters; R Kooijman
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

7.  Effect of prolactin on carcinoembryonic antigen-specific cytotoxic T lymphocyte response induced by dendritic cells.

Authors:  L Matera; E Beltramo; E Martinuzzi; S Buttiglieri
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.